Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesCorticosteroids (dexamethasone versus intravenous methylprednisolone) in patients with tuberculous meningitis
Annals of Tropical Medicine and Parasitology, 10/15/09
Malhotra HS et al. – In an open–label study in India, 97 patients with such meningitis were randomized into a control group, a dexamethasone group (with the drug given intravenously once a day for 4 weeks, and then orally, once daily, for another 4 weeks) and a methylprednisolone group (with the drug given intravenously once a day for 5 days). Adverse events were similar and equally reported in the two corticosteroid groups. Larger trials are still needed to determine if dexamethasone and/or methylprednisolone are useful in the treatment of tuberculous meningitis, at least in India.
Today in CNS Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Penetration of Colistin into Cerebrospinal Fluid
Antimicrobial Agents and Chemotherapy, 11/05/09
Epidemiology, Prevention and Management of Ventriculoperitoneal Shunt Infections in Children
Pediatric Neurosurgery, 11/11/09
Magnetic resonance imaging in central nervous system tuberculosis
Indian Journal of Radiology and Imaging, 10/29/09
Sponsor
Article Search
Sponsor